UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Alzheimer's research & therapy, 2020-09, Vol.12 (1), p.1-118, Article 118

2020

Volltextzugriff (PDF)

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results

Clinical chemistry (Baltimore, Md.), 2018-03, Vol.64 (3), p.576-585

2018

Volltextzugriff (PDF)

Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2169-2182

2021

Volltextzugriff (PDF)

Quantification of [18F]florbetapir: A test–retest tracer kinetic modelling study

Journal of cerebral blood flow and metabolism, 2019-11, Vol.39 (11), p.2172-2180

2019

Volltextzugriff (PDF)

Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions

Frontiers in psychiatry, 2022-06, Vol.13, p.877460-877460

2022

Volltextzugriff (PDF)

Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report

Frontiers in aging neuroscience, 2022-01, Vol.13, p.761932-761932

2022

Volltextzugriff (PDF)

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

JMIR formative research, 2019-07, Vol.3 (3), p.e13417-e13417

2019

Volltextzugriff (PDF)

Dutch Brain Research Registry for study participant recruitment: Design and first results

Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12132-n/a

2021

Volltextzugriff (PDF)

ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics

Alzheimer's research & therapy, 2019-08, Vol.11 (1), p.77-77, Article 77

2019

Volltextzugriff (PDF)

Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2018, Vol.10 (1), p.563-572

2018

Volltextzugriff (PDF)

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2024-01, Vol.16 (1), p.e12541-n/a

2024

Volltextzugriff (PDF)

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

Alzheimer's research & therapy, 2019-09, Vol.11 (1), p.78-78, Article 78

2019

Volltextzugriff (PDF)

FindMyApps compared with usual tablet use to promote social health of community-dwelling people with mild dementia and their informal caregivers: a randomised controlled trial

EClinicalMedicine, 2023-09, Vol.63, p.102169, Article 102169

2023

Volltextzugriff (PDF)

Pre‐amyloid stage of Alzheimer's disease in cognitively normal individuals

Annals of clinical and translational neurology, 2018-09, Vol.5 (9), p.1037-1047

2018

Volltextzugriff (PDF)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases

Alzheimer's research & therapy, 2019-12, Vol.11 (1), p.100-100, Article 100

2019

Volltextzugriff (PDF)

Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

The Journal of nuclear medicine (1978), 2019-04, Vol.60 (4), p.541-547

2019

Volltextzugriff (PDF)

General practitioners’ attitude toward early and pre‐dementia diagnosis of AD in five European countries—A MOPEAD project survey

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12130-n/a

2021

Volltextzugriff (PDF)

The Cognitive Online Self‐Test Amsterdam (COST‐A): Establishing norm scores in a community‐dwelling population

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12234-n/a

2021

Volltextzugriff (PDF)

Clinician-patient communication during the diagnostic workup: The ABIDE project

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.520-528

2019

Volltextzugriff (PDF)

Diagnostic impact of biomarkers including CSF and PET in a tertiary memory clinic

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P263-P263

2015

Volltextzugriff (PDF)

CLINICIANS’ VIEWS AND ATTITUDES ON SHARED DECISION MAKING IN DIAGNOSTIC TESTING FOR ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P595-P595

2016

Volltextzugriff (PDF)

DECIDING ABOUT DIAGNOSTIC TESTING FOR ALZHEIMER’S DISEASE: PATIENTS’ VIEWS AND EXPERIENCES

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1122-P1122

2016

Volltextzugriff (PDF)

AMYLOID LEVELS IN THE NORMAL RANGE ARE PREDICTIVE FOR INCIDENT DEMENTIA IN NON-DEMENTED ELDERLY

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1055-P1056

2016

Volltextzugriff (PDF)

Diagnostic impact of [18 F]flutemetamol amyloid imaging in young-onset dementia

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P3-P4

2015

Volltextzugriff (PDF)

Diagnostic impact of [18 F]flutemetamol amyloid imaging in young onset dementia

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P411-P412

2015

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(129)

Sprache

Englisch
(127)
Niederländisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results

Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent

Quantification of [18F]florbetapir: A test–retest tracer kinetic modelling study

Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions

Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

Dutch Brain Research Registry for study participant recruitment: Design and first results

ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics

Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

FindMyApps compared with usual tablet use to promote social health of community-dwelling people with mild dementia and their informal caregivers: a randomised controlled trial

Pre‐amyloid stage of Alzheimer's disease in cognitively normal individuals

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases

Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

General practitioners’ attitude toward early and pre‐dementia diagnosis of AD in five European countries—A MOPEAD project survey

The Cognitive Online Self‐Test Amsterdam (COST‐A): Establishing norm scores in a community‐dwelling population

Clinician-patient communication during the diagnostic workup: The ABIDE project

Diagnostic impact of biomarkers including CSF and PET in a tertiary memory clinic

CLINICIANS’ VIEWS AND ATTITUDES ON SHARED DECISION MAKING IN DIAGNOSTIC TESTING FOR ALZHEIMER’S DISEASE

DECIDING ABOUT DIAGNOSTIC TESTING FOR ALZHEIMER’S DISEASE: PATIENTS’ VIEWS AND EXPERIENCES

AMYLOID LEVELS IN THE NORMAL RANGE ARE PREDICTIVE FOR INCIDENT DEMENTIA IN NON-DEMENTED ELDERLY

Diagnostic impact of [18 F]flutemetamol amyloid imaging in young-onset dementia

Diagnostic impact of [18 F]flutemetamol amyloid imaging in young onset dementia

Aktive Filter

Suchergebnisse filtern